SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021336
Filing Date
2017-11-03
Accepted
2017-11-02 19:14:55
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20170930.htm 10-Q 1641855
2 EX-31.1 rare-ex311_6.htm EX-31.1 17452
3 EX-31.2 rare-ex312_10.htm EX-31.2 17453
4 EX-32.1 rare-ex321_8.htm EX-32.1 10882
5 GRAPHIC g2017110222545994314720.jpg GRAPHIC 38587
  Complete submission text file 0001564590-17-021336.txt   4558397

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20170930.xml EX-101.INS 827712
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20170930.xsd EX-101.SCH 33995
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20170930_cal.xml EX-101.CAL 38631
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20170930_def.xml EX-101.DEF 90430
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20170930_lab.xml EX-101.LAB 245456
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20170930_pre.xml EX-101.PRE 176893
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 171174211
SIC: 2834 Pharmaceutical Preparations